Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
Erik C. B. Johnson, Kathleen Carter, Eric B. Dammer, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 2, pp. 213-225
Open Access | Times Cited: 368

Showing 1-25 of 368 citing articles:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 335
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
Ashley N. Brandebura, Adrien Paumier, Tarik Seref Onur, et al.
Nature reviews. Neuroscience (2022) Vol. 24, Iss. 1, pp. 23-39
Open Access | Times Cited: 260
Organ aging signatures in the plasma proteome track health and disease
Hamilton Oh, Jarod Rutledge, Daniel Nachun, et al.
Nature (2023) Vol. 624, Iss. 7990, pp. 164-172
Open Access | Times Cited: 230
Shared mechanisms across the major psychiatric and neurodegenerative diseases
Thomas S. Wingo, Yue Liu, Ekaterina S. Gerasimov, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 117
Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
Eric B. Dammer, Lingyan Ping, Duc M. Duong, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 105
APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge
Sangderk Lee, Nicholas A. Devanney, Lesley R. Golden, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112196-112196
Open Access | Times Cited: 93
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
Erik C. B. Johnson, Shijia Bian, Rafi U. Haque, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1979-1988
Open Access | Times Cited: 93
Compilation of reported protein changes in the brain in Alzheimer’s disease
Manor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
Betty M. Tijms, Eleonora M. Vromen, Olav Mjaavatten, et al.
Nature Aging (2024) Vol. 4, Iss. 1, pp. 33-47
Open Access | Times Cited: 81
Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease
Marzia Perluigi, Fabio Di Domenico, D. Allan Butterfield
Physiological Reviews (2023) Vol. 104, Iss. 1, pp. 103-197
Closed Access | Times Cited: 77
Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Tracy L. Young‐Pearse, Hyo Lee, Yi‐Chen Hsieh, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 6, pp. 426-444
Open Access | Times Cited: 49
Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology
Prateek Kumar, Annie M Goettemoeller, Claudia Espinosa‐García, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia
Jordan D. Marks, Virginia Estades Ayuso, Yari Carlomagno, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 730
Open Access | Times Cited: 17
Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment
Eric B. Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 16
Proteomic changes in Alzheimer disease associated with progressive Aβ plaque and tau tangle pathologies
Alexa Pichet Binette, Chris Gaiteri, Malin Wennström, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 10, pp. 1880-1891
Open Access | Times Cited: 16
The pathobiology of neurovascular aging
Monica M. Santisteban, Costantino Iadecola
Neuron (2025) Vol. 113, Iss. 1, pp. 49-70
Closed Access | Times Cited: 3
The TRPV1-PKM2-SREBP1 axis maintains microglial lipid homeostasis in Alzheimer’s disease
Xudong Sha, Jiayuan Lin, Kexin Wu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer’s disease, and late-onset Alzheimer’s disease
Mitchell Martà-Ariza, Dominique Leitner, Evgeny Kanshin, et al.
Acta Neuropathologica (2025) Vol. 149, Iss. 1
Open Access | Times Cited: 2
Contributions of Genetic Variation in Astrocytes to Cell and Molecular Mechanisms of Risk and Resilience to Late‐Onset Alzheimer's Disease
Hyo Lee, Richard V. Pearse, Alexandra M. Lish, et al.
Glia (2025)
Open Access | Times Cited: 2
Human and mouse proteomics reveals the shared pathways in Alzheimer’s disease and delayed protein turnover in the amyloidome
Jay M. Yarbro, Xian Han, Abhijit Dasgupta, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Spatial proteomics in three-dimensional intact specimens
Harsharan S. Bhatia, Andreas‐David Brunner, Furkan Öztürk, et al.
Cell (2022) Vol. 185, Iss. 26, pp. 5040-5058.e19
Open Access | Times Cited: 68
Aberrant astrocyte protein secretion contributes to altered neuronal development in multiple models of neurodevelopmental disorders
Alison L. M. Caldwell, Laura Sancho, James Deng, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 9, pp. 1163-1178
Open Access | Times Cited: 58
Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease
Tain Luquez, Pallavi Gaur, Ivy M Kosater, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 42
Sex differences in brain protein expression and disease
Aliza P. Wingo, Yue Liu, Ekaterina S. Gerasimov, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2224-2232
Open Access | Times Cited: 39
Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease
Cheyenne Hurst, Derian A. Pugh, Measho Abreha, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 5, pp. 100542-100542
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top